Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptolide for autosomal dominant polycystic kidney disease with proteinuria
ChiCTR-TRC-11001282Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Apr 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triptolide, losartan in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Shanghai Changzheng Hospital. Started Apr 2011; status: completed.
02
Drugs
triptolidelosartan
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001282.